Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Raffaele Colombo
Feb 22, 2024, 18:56 |
Blog
Raffaele Colombo: Application based on results from the TROPION-Lung01 phase 3 trial
Raffaele Colombo, Principal Scientist & Group Lead, Medicinal Chemistry at Zymeworks, shared on X/Twitter: "Application based…
Jan 24, 2024, 22:30 |
Insight
Raffaele Colombo: Evoke-01 study of sacituzumab govitecan (SG) did not meet its primary overall survival goal in patients with NSCLC
Raffaele Colombo, Principal Scientist at Zymeworks, shared on X: "Evoke-01 study of sacituzumab govitecan (SG)…
Nov 15, 2023, 17:08 |
History
Raffaele Colombo: Can you believe these were written almost 40 years ago?
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute shared a post on Twitter by…
Nov 4, 2023, 00:58 |
Drugs
Raffaele Colombo: Here the breakdown of the Monomethyl auristatin E Antibody Drug Conjugates
Raffaele Colombo, Principal Scientist at Zymeworks, shared on X/Twitter: 106 auristatin Antibody Drug Conjugates (ADCs)…
Oct 10, 2023, 00:45 |
Blog
Raffaele Colombo: Remember the days of meeting handouts? And having all the ADCs summarized in one page?
Raffaele Colombo, Principal Scientist and Group Lead, Medicinal Chemistry at Zymeworks Inc., made the following post…
Oct 2, 2023, 18:10 |
Insight
Raffaele Colombo: ADC history.
Quoting Raffaele Colombo, Principal Scientists at Zyme Works on X/Twitter: “Maytansine was isolated in the…
Aug 14, 2023, 17:26 |
Insight
Raffaele Colombo: WHO INN proposed list 129 is out.
In a Twitter post by Raffaele Colombo, Principal Scientist at Zymeworks Inc, it says: ''WHO…
Sep 26, 2024, 14:19 |
Blog
Paolo Tarantino: ADC stability does not equal ADC tolerability
Paolo Tarantino shared a post by Raffaele Colombo, on X, adding: ''Antibody-drug conjugate (ADC) stability…
Sep 21, 2024, 01:25 |
Insight
Paolo Tarantino: 10 facts to know to prepare for the rise of ADCs
Paolo Tarantino shared on X: “ADCs are among the most rapidly expanding treatment modalities in…
Sep 13, 2024, 07:23 |
Blog
Paolo Tarantino: List for the upcoming early-phase ADCs at ESMO24
Paolo Tarantino shared a post by Raffaele Colombo on X, adding: "Terrific list of ADC data to…
1
2
3
4
All:
31
Posts:
11 - 20
Inside OncoDaily Party Barcelona
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube